CARA FEHNEL: Open Payments
NPI 1184082349 · EATONTOWN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$526 in 11 payments from 8 companies in 2025. Trend: 2023 $62 · 2024 $66 · 2025 $526
Food & beverage: $526
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $186 |
| Alnylam Pharmaceuticals Inc. | 1 | $147 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $45 |
| HEARTFLOW, INC. | 2 | $38 |
| Amgen Inc. | 2 | $33 |
| Medtronic, Inc. | 1 | $32 |
| Abbott Laboratories | 1 | $26 |
| Merck Sharp & Dohme LLC | 1 | $18 |
Products named: WAINUA, AMVUTTRA, LifeVest, FFRct, REPATHA, SYMPLICITY G3, AVEIR, VERQUVO.
Industry payments across NJ — which companies pay providers there.
